Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Bristol Myers Squibb Co. and every other company we cover.
Try it first on NVDA, AAPL, META or NKE, where it is open to everyone.
BMY · NYSE · ·
Next earnings: October 29, 2026 · before the open
$62.88-1.6%Sep 29 close
Bristol Myers Squibb discovers, makes and sells prescription medicines for cancer, blood disorders, immune conditions, heart disease and mental health conditions.